Participating Faculty: Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)

This supplement to The American Journal of Managed Care summarizes proceedings from a roundtable meeting that was conducted to discuss the diagnosis of Parkinson’s disease and distinguish clinical criteria and algorithms to help guide clinicians and managed care organizations in the application of DaTscan SPECT imaging. This meeting and publication were supported by GE Healthcare, Princeton, NJ.

Faculty

Jeffrey L. Cummings, MD, ScD—Moderator

Director

Cleveland Clinic Lou Ruvo Center For Brain Health

Las Vegas, Nevada

Professor

Cleveland Clinic Lerner College of Medicine

Case Western Reserve University

Cleveland, Ohio

Michael J. Fine, MD

Medical Director

Health Net

Huntington Beach, California

Igor D. Grachev, MD, PhD

Global Head of DaTscan

Medical Affairs

GE Healthcare-Life Sciences

Princeton, New Jersey

C. Rick Jarecke, PharmD

Medical Director

GE Healthcare-Life Sciences

Princeton, New Jersey

Meridith K. Johnson, MSc

Director

Health Economics and Outcomes Research

GE Healthcare

Chalfont St Giles, UK

Phillip H. Kuo, MD, PhD

Associate Professor of Medical Imaging, Medicine, and Biomedical Engineering

Section Chief of Nuclear Medicine

University of Arizona

Tucson, Arizona

Joyce A. Oberdorf

President and Chief Executive Officer

National Parkinson Foundation

Miami, Florida

Michael Rezak, MD, PhD

Director, Movement Disorders Center

Neuroscience Institute

Central DuPage Hospital

Winfield, Illinois

David E. Riley, MD

Movement Disorders Center

Neurological Institute

University Hospitals

Cleveland, Ohio

Professor

Department of Neurology

Case Western Reserve University School of Medicine

Cleveland, Ohio

Kenneth L. Schaecher, MD, FACP, CPC

Medical Director

SelectHealth

Murray, Utah

Daniel Truong, MD

The Parkinson and Movement Disorder Institute

Orange Coast Memorial Medical Center

Fountain Valley, California

Acknowledgments

David S. Russell, MD, PhD, participated in the roundtable meeting and James Borwick provided editorial support for this publication.

Faculty Disclosures

These faculty report relationships with the following organizations:

Jeffrey L. Cummings, MD, ScD

Consultant/paid advisory board member/honoraria: GE Healthcare

Igor D. Grachev, MD, PhD

Employment: GE Healthcare

C. Rick Jarecke, PharmD

Employment/stock ownership: GE Healthcare

Meridith K. Johnson, MSc

Employment: GE Healthcare

Phillip H. Kuo, MD, PhD

Consultant/paid advisory board member/grants/honoraria/lecture fees: GE Healthcare

Joyce A. Oberdorf

Honoraria: GE Healthcare

Michael J. Fine, MD; Michael Rezak, MD, PhD; David E. Riley, MD; Kenneth L. Schaecher, MD, FACP, CPC; and Daniel Truong, MD, report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this supplement.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

Download PDF: Participating Faculty: Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)